| 摘要 |
The present invention concerns novel variants, amino acid and nucleic acid sequences obtained by alternative splicing of known sequences, expression vectors and host cells containing the variants' nucleic acid sequence, and antibodies reactive with the variants' products. The invention also concerns pharmaceutical compositions containing any of the above as well as methods of detection. A preferred example is the angiotensin converting enzyme (ACE) variant. |
